Related Experiment Video
Updated: Aug 18, 2025

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
[Antiviral Activity of CRISPR/Cas9 Ribonucleoprotein Complexes on a Hepatitis B Virus Model In Vivo]
A P Kostyusheva1, S A Brezgin1,2, N I Ponomareva1,2
1Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases (Sechenov University), Moscow, 119048 Russia.
CRISPR/Cas9 gene editing offers a promising strategy for a functional cure of chronic hepatitis B (CHB). A single CRISPR/Cas9 treatment significantly reduced hepatitis B virus (HBV) DNA levels in a mouse model.
Area of Science:
- Molecular Biology
- Hepatology
- Gene Therapy
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Related Concept Videos
CRISPR
The Antiviral System of Bacteria and Archaea: CRISPR
CRISPR/Cas9 Genome Editing
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Viruses with RNA Genomes